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Background: S-methylmethionine sulfonium chloride was 
originally called vitamin U because of its inhibition of 
ulceration in the digestive system. Vitamin U is ubiquitously 
expressed in the tissues of flowering plants, and while there 
have been reports on its hypolipidemic effect, its precise 
function remains unknown. Objective:  This study was 
designed to evaluate the anti-obesity effect of vitamin U in 
3T3-L1 pre-adipocyte cell lines. Methods: We cultured the 
pre-adipocyte cell line 3T3L1 to overconfluency and then 
added fat differentiation-inducing media (dexamethasone, 
IBMX [isobutylmethylxanthine], insulin, indomethacin) and 
different concentrations (10, 50, 70, 90, 100 mM) of vitamin 
U. Then, we evaluated changes in the levels of triglycerides 
(TGs), glycerol-3-phosphate dehydrogenase (G3PDH), 
AMP-activated protein kinase (AMPK), adipocyte-specific 
markers (peroxisome proliferator-activated receptor γ 
[PPAR-γ], CCAAT/enhancer-binding protein α  [C/EBP-α], 
adipocyte differentiation and determination factor 1 
[ADD-1], adipsin, fatty acid synthase, lipoprotein lipase) and 
apoptosis-related signals (Bcl-2, Bax). Results: There was a 
gradual decrease in the level of TGs, C/EBP-α, PPAR-γ, 
adipsin, ADD-1 and GPDH activity with increasing concen-
trations of vitamin U. In contrast, we observed a significant 
increase in AMPK activity with increasing levels of vitamin 
U. The decrease in bcl-2 and increase in Bax observed with 
increasing concentrations of vitamin U in the media were not 
statistically significant. Conclusion: This study suggests that 
vitamin U inhibits adipocyte differentiation via down- 
regulation of adipogenic factors and up-regulation of AMPK 
activity. (Ann Dermatol 24(1) 39∼44, 2012)
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INTRODUCTION
Adipose tissue serves as an energy storage depot to 
maintain lipid homeostasis, thereby promoting the sur-
vival of the human body. Obesity occurs when the 
adipose tissue is overloaded with high-energy nutrients 
without subsequent expenditure
1.
Because adipocytes play a critical role in energy balance 
through the storage of triglycerides (TGs) or the release of 
free fatty acids in response to changes in energy demands, 
understanding the molecular mechanisms of adipocyte 
differentiation may provide clues for the development of 
strategies for the prevention and treatment of obesity. The 
mechanisms of adipocyte differentiation have been exten-
sively studied in preadipocyte culture systems. Charac-
terization of the regulatory regions of adipose-specific 
genes has led to the identification of key transcription 
factors in the complex transcriptional cascade that occurs 
during adipocyte differentiation
2. These factors include 
peroxisome proliferator-activated receptor γ (PPAR-γ)
3, 
CCAAT/enhancer binding protein (C/EBP)
4,5, adipocyte NY Lee, et al
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differentiation and determination factor 1 (ADD-1)
6, fatty 
acid synthase (FAS) and lipoprotein lipase (LPL)
7.
In addition to playing a central role in the storage of lipids, 
adipose tissue secretes numerous bioactive substances 
called adipokines that contribute to cell proliferation as 
well as the differentiation of preadipocytes into adipocytes. 
These substances include tumor necrosis factor-α, adi-
ponectin, adipsin, and interleukin-6 (IL-6), which also 
regulate the inflammatory response
8-14.
Recently, a number of natural compounds, such as herbal 
drugs and flavonoids, have received considerable attention 
for their abilities to regulate adipogenesis. S-methyl-
methionine sulphonium chloride is abundant in the tissues 
of flowering plants, especially in raw cabbage, and has 
also been called vitamin U (from the Latin ‘ulcus’ meaning 
sore or ulcer
15), although its classification as a vitamin has 
not yet been accepted
16. Gessler et al.
17 reported that 
vitamin U can decrease the level of lipid peroxidation and 
inhibit monoamine oxidase activity. Also, they reported 
that vitamin U has a hypolipidemic effect. 
Our study was conducted to determine whether vitamin U 
can modulate differentiation in 3T3-L1 adipocytes. The 
involvement of glycerol-3-phosphate dehydrogenase (G3PDH), 
AMP-activated protein kinase (AMPK) and adipocyte- 
specific markers (PPAR-γ, C/EBP-α, ADD-1, adipsin, FAS, 
and LPL) were evaluated.  
MATERIALS AND METHODS
Culture and differentiation of 3T3-L1
3T3-L1 cells and vitamin U were purchased from the 
Korea Cell Line Bank (Seoul, Korea) and TCI Corp. (Tokyo, 
Japan), respectively. 3T3-L1 preadipocytes were incubated 
at a density of 8,000 cells/cm
2 (10 cm
2 dish) and grown in 
Dulbecco’s modified Eagle’s medium (DMEM) containing 
10% fetal bovine serum (FBS) at 37
oC in 5% CO2 in air. 
Confluent preadipocytes were induced to differentiate 
with inducing medium containing 500 μM IBMX (isobutyl-
methylxanthine), 1 μM dexamethasone, 100 μM indome-
thacin and 10 μg/ml insulin. To test the effect of vitamin 
U on inhibition of adipocyte differentiation, we treated 
cells with vitamin U (10, 50, 70, or 100 mM) at day 0. To 
test the effect of vitamin U on fat in adipocytes, we 
changed the medium to DMEM (with 10% FBS) on day 6 
after the induction of adipocyte differentiation and then 
treated the cells with vitamin U at different concen-
trations for seven days. Cultures were re-fed every 2-3 
days to allow 90% of the cells to reach full differentiation 
before they were chemically treated. Chemicals were 
freshly diluted in adipocyte medium before treatment. 
Cells were washed with fresh adipocyte medium, re-fed 
with medium containing vitamin U, and then incubated at 
37
oC in 5% CO2 in air before analysis. 
Cell viability assay (MTT assay) 
3T3-L1 cells were treated with lipopolysaccharide (100 
ng), interferon-γ (10 ng) and different concentrations of 
S-methylmethionine sulfonium chloride (50, 70, 90, 100 
mM). After cells were incubated for 24 hr, MTT (5 mg/ml) 
was added. Then, the supernatant was discarded, dimethyl 
sulfoxide was added to the cells and formazan was formed 
via MTT reduction. Cell viability was measured using an 
ELISA at 570 nm.
Oil Red O staining
The formation of oil droplets in cells was analyzed using 
Oil Red O staining as follows. After removal of culture 
medium, cells were washed twice with phosphate-buffered 
saline (PBS) and then fixed for at least one hour with 
pre-chilled 10% formaldehyde in PBS. Cells were stained 
with 0.7% Oil Red O solution for two hours, followed by 
three washes with PBS. Cells were maintained in water 
and photographed. Fat droplets in the adipocytes were 
stained red, and the Oil Red O stain was eluted with 
isopropanol and was quantified by measuring the optical 
density  at 515 nm.  
TG assay
3T3-L1 adipocytes that were treated as described above 
were washed with PBS, harvested into 25 mM Tris buffer 
(pH 7.5) containing 1 mM ethylenediaminetetraacetic acid 
(EDTA), and lysed via brief sonication. We quantified TG 
levels in the lysates using the LabAssay
TM Triglyceride kit 
(Wako Pure Chemical Industries. Ltd., Osaka, Japan).
G3PDH activity assay
After removal of the culture medium, cells were washed 
twice with PBS and lysed in enzyme extraction buffer. 
Immediately after the extraction, we added an equal 
volume of dilution buffer supplemented with 2-mercaptoethanol 
to the sample to prepare a two-fold diluent. We dispensed 
the substrate solution into each 96-well plate and 
preincubated the plate at 30
oC. We then added 25 μl of a 
diluted sample and agitated the plate and determined the 
decrease in absorbance at 340 nm at 30
oC.
Reverse transcriptase polymerase chain reaction 
Mouse adipocyte-specific markers (PPAR-γ, C/EBP-α, ADD-1, 
adipsin, FAS, LPL) were quantitatively measured using an 
RNeasy Lipid mini kit (Qiagen, Austin, TX, USA). The 
primers and probe sets were ordered from Bioneer Corp. 
(Daejeon, Korea) and were used according to the manu-Inhibitory Effect of Vitamin U on Adipocyte Differentiation
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Table 1. Primer sequences for reverse transcription PCR
Target Sequence Target Sequence
  PPAR-γ F : aga cat cag cgc cta cat cg Adipsin F : gcc tga tgt cct gca tca ac
R : gct ccc ggg tag tca aag tc R : ttt tcg atc cac atc cgg ta
  C/EBP-α F : aga cat cag cgc cta cat cg LPL F : aga aaa ccc cag caa agc at
R : gct ccc ggg tag tca aag tc R : gag aaa ttt cga agg cct gg
  ADD-1 F : agg cac act tca tca agg cag FAS F : tga agg tga aca agg caa gc
R : ggt agc gct tct caa tgg cat R : ggg tcg ata tag atg gcg gt
PCR: polymerase chain reaction, PPAR-γ: peroxisome proliferator-activated receptor γ, C/EBP-α: CCAAT/enhancer binding protein
α, ADD-1: adipocyte differentiation and determination factor 1, F: forward primer, R: reverse primer, LPL: lipoprotein lipase, FAS:
fatty acid synthase.
Fig. 1. Cell viability of vitamin U at different concentrations in 
3T3-L1 cell lines. The results show a slight decrease in viability
with higher concentrations of vitamin U. However, no statistically
significant differences were observed. 
facturer’s instructions. The probe and primer sequences 
are shown in Table 1.
Western blot assay
Cells were incubated in a humidified 5% CO2 incubator. 
They were collected and lysed in ice-cold lysis buffer (20 
mM Tris-HCl (pH 7.4), 2 mM EDTA, 500 μM sodium 
orthovanadate, 1% Triton X-100, 0.1% SDS, 10 mM NaF, 
10 μg/ml leupeptin and 1 mM PMSF). The protein con-
centration was estimated with the Bio-Rad DC protein 
assay (Bio-Rad Laboratories, Hercules, CA, USA) using 
bovine serum albumin as a standard. Total protein (50∼60 
μg) was separated using sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) in a 10% polyacrylamide 
gel. The proteins in the gel were transferred to a nitro-
cellulose membrane. The membrane was blocked with 
5% skim milk in PBST (0.1% v/v Tween-20 in PBS, pH 
7.2) for 1 h. Membranes were incubated with primary 
antibody at 4
oC overnight and then with a secondary 
antibody for 1 h. Membranes were washed in PBST for ten 
min, three times between each step. The signal was 
detected using the Amersham ECL system (Amersham- 
Pharmacia Biotech, Arlington Heights, IL, USA). The 
relative expressions of PPAR-γ and AMPK in 3T3-L1 
adipocytes were quantified densitometrically using Image 
J software and were calculated according to the reference 
bands of β-actin.
Statistical analysis
Data are presented as the mean±SEM of at least three 
independent experiments performed in triplicate. Values 
of p＜0.05 were considered to be significant.
RESULTS
Cell viability of 3T3-L1 cells after treatment with 
different concentrations of vitamin U 
3T3-L1 cell viability after treatment with different con-
centrations of vitamin U was measured using the MTT 
assay. The results showed that cell viability decreased 
slightly as the concentration of vitamin U increased (Fig. 
1). However, the differences in cell viability were not 
statistically significant compared with that of the controls.
Effect of vitamin U on the inhibition of adipocyte 
differentiation according to Oil Red O staining, TG 
assay and G3PDH activity assay
The effects of vitamin U on adipocyte differentiation were 
evaluated using Oil Red O staining and through the 
analysis of cellular TG content and G3PDH activity. Oil 
droplets were abundant in differentiated adipocytes, and 
the number of oil droplets was significantly lower than 
that in the untreated control cells (Fig. 2A, B). Consistent 
with the appearance of the formed oil droplets, vitamin U 
significantly reduced cellular TG levels in a concentration- 
dependent manner (Fig. 2C). We found that vitamin U 
significantly inhibited intracellular G3PDH (Fig. 2D).NY Lee, et al
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Fig. 2. Effect of vitamin U on the inhibition of adipocyte differentiation in Oil Red O staining, triglyceride (TG) assay and 
glycerol-3-phosphate dehydrogenase (G3PDH) activity assay. Oil droplets were abundant in differentiated adipocytes, and the number 
of oil droplets decreased with vitamin U treatment in a concentration-dependent manner (A, B). Consistent with the appearance of 
formed oil droplets, vitamin U significantly reduced cellular TG levels in a concentration-dependent manner (C). We found that vitamin 
U resulted in a significant inhibition of intracellular G3PDH (D). *Significant at p＜0.05. ND: non-differentiated, NT: non-treated, 
Vit U: vitamin U, OD: optical density, G3PDH: glycerol-3-phosphate dehydrogenase.
Effect of vitamin U on the expression of PPAR-γ, 
C/EBP-α, ADD-1, adipsin, FAS and LPL in 3T3-L1 
adipocytes
To study the mechanisms by which vitamin U inhibits 
adipocyte differentiation, we assessed the effects of 
vitamin U on the expression of PPAR-γ, C/EBP-α, ADD-1, 
adipsin, FAS and LPL. The mRNA levels of C/EBP-α, 
ADD-1 and adipsin were decreased, and both the mRNA 
and protein levels of PPAR-γ were substantially de-
creased by vitamin U in a dose dependent manner. 
Vitamin U did not significantly block the induction of LPL 
or FAS (Fig. 3).
Effect of vitamin U on activation of AMPK
AMPK activation was examined using western blot 
analysis. AMPK phosphorylation increased with vitamin U 
treatment in a dose-dependent manner during adipogenic 
differentiation (Fig. 4).
DISCUSSION 
This study suggests that vitamin U inhibits adipocyte 
differentiation via down-regulation of adipogenic factors. 
We investigated the effects of vitamin U on the inhibition 
of intracellular TG and G3PDH activities, marker enzymes Inhibitory Effect of Vitamin U on Adipocyte Differentiation
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Fig. 3. Effects of vitamin U on the expressions of PPAR-γ, C/EBP-
α, ADD-1, adipsin, FAS and LPL in 3T3-L1 adipocytes. The 
mRNA levels of C/EBP-α, ADD-1 and adipsin decreased, and
both the mRNA and protein levels of PPAR-γ remarkably
decreased with vitamin U treatment (A, B). DM: differentiated
media, Vit U: vitamin U, PPAR-γ: peroxisome proliferator-
activated receptor γ, C/EBP-α: CCAAT/enhancer binding 
protein α, FAS: fatty acid synthase, ADD-1: adipocyte differentiation
and determination factor 1, LPL: lipoprotein lipase.
Fig. 4. Effect of vitamin U on activation of AMP-activated protein 
kinase (AMPK) detected using western blotting. Protein levels of
phosphorylated AMPK increased with vitamin U treatment in a
dose-dependent manner during adipogenic differentiation (A, B).
DM: differentiated media, Vit U: vitamin U, AMPK: AMP-activated
protein kinase, ND: non-differentiated, NT: non-treated. *Signi-
ficant at p＜0.05. 
of adipogenesis, in 3T3-L1 adipocytes. Fasting induces 
conversion of glycerol into TG through an induction of 
several hepatic enzymes such as G3PDH and glycerol 
kinase. Tomiyama et al.
18 indicated that the expression of 
G3PDH is induced several fold upon conversion of 
preadipocytes to adipocytes, which is the predominant 
substrate for TG synthesis in adipose tissue. Our data 
indicated that the exposure of 3T3-L1 adipocytes to 
vitamin U results in lower levels of intracellular TGs and 
G3PDH than did other compounds tested. Adipose tissue 
is now known to produce and secrete PPAR-γ, C/EBP-α, 
ADD-1 and adipsin, which have roles in adipocyte differen-
tiation because they are transcriptional factors for 
numerous genes
3-6,9. The present experiment indicated 
that vitamin U treatment inhibited the mRNA expression 
levels of PPAR-γ, C/EBP-α, ADD-1 and adipsin, which 
demonstrates that adipogenesis is inhibited by the 
upstream transcriptional factor cascade. There were no 
noticeable changes in mRNA levels of LPL or FAS, which 
indicates that vitamin U does not affect adipocyte function 
itself. 
Here, we present evidence that vitamin U inhibits 
adipocyte differentiation through the activation of AMPK. 
AMPK is a well-known metabolic master switch, activated 
by various stimuli, including exercise, hypoxia and 
reactive oxygen species
19. Once activated, AMPK blocks 
anabolic pathways and promotes catabolic pathways, 
protecting the cell from various stress stimuli
20. Hwang et 
al.
21 suggested that several naturally occurring compounds, 
such as genistein, EGCG and capsaicin, activate AMPK in 
a dose-dependent manner, leading to the inhibition of 
adipocyte differentiation. 
Although we found that AMPK and adipocyte differen-
tiation factors (PPAR-γ, C/EBP-α, ADD-1 and adipsin) 
are involved in the antiobesity effects exerted by vitamin 
U, no direct correlation was found between AMPK and 
the signaling pathways of other adipocyte differentiation 
factors. Therefore, possible connections between AMPK 
and the signaling pathways of other adipocyte differentiation 
factors should be investigated in future studies.
In the present study, we elucidated the inhibitory effects of NY Lee, et al
44 Ann Dermatol
vitamin U on 3T3-L1 adipocytes, as indicated by decreases 
in intracellular TG content and G3PDH activity. The 
inhibitory effect of vitamin U appears to be mediated by 
the down-regulated expressions of adipogenic transcription 
factors (PPAR-γ, C/EBP-α and ADD-1) and adipocyte- 
specific proteins (adipsin) and the upregulated expression 
of AMPK. Since obesity is a social issue and a well- 
established risk factor for cardiovascular disease and 
diabetes, our study suggests that it may be worthwhile to 
determine if vitamin U has an inhibitory effect on 
adipogenesis in vivo.
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